The news comes after Siemens confirmed a 20% year-over-year revenue decline to about €1.1bn for its diagnostics arm in its third quarter. Credit: Shutterstock / HJBC

Siemens Healthineers has confirmed that it plans to lay off as many as 300 members of staff from its diagnostics and manufacturing division amid restructuring efforts across the company.

In a notice to the US state of New Jersey, the firm announced that it would end 300 jobs at the Siemens Healthcare Diagnostics manufacturing facility in Flanders, New Jersey.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

New Jersey law requires that lay offs involving 50 or more members of staff require the state to be formally notified.

The firm announced the layoffs as it seeks to transfer manufacturing of its Atellica Solution instrument operations to Dublin by the end of 2024.

The notice shows that 300 of the proposed layoffs will centre around the firm’s diagnostics business after the company announced in its 2023 Q4 report that it would be restructuring itself in a bid to save €300m.

See Also:

Following the announcement, Siemens Healthineer’s stock price dropped from an estimated €49.50 per share on Friday 3 November, down to €47.46 on Tuesday 7 November.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In August of this year, the company confirmed a 20% year-over-year revenue decline to about €1.1bn for its diagnostics arm in its third quarter, blaming the decline on the dropping sales of Covid-19 rapid antigen tests.

It also comes as Reuters reports that the company may be looking to sell off its diagnostic imaging arm.

GlobalData’s Healthcare Intelligence Centre found that in 2022 Siemens Healthineers saw  revenue of around $25.6bn , up more than 20% from 2021.

Editor’s note: This story has been updated with a correction. 300 jobs were cut by Siemens Healthineers at the New Jersey facility, not 750.